A new report from the American Cancer Society offers a clear look at how the country is faring in the fight against cancer, and the data show that ongoing research is driving real progress for patients.

Last week, U.S. Rep. Terri Sewell, D-Ala., celebrated the passage of a bipartisan piece of legislation to ensure emerging cancer blood tests are covered by Medicare.

As we get older, chemical marks on our DNA slowly shift.

Colorectal cancer has become the leading cause of cancer-related deaths among people younger than 50 in the United States, according to new research.

A new study suggests a common eye condition could be quietly masking one of the only early warning signs of bladder cancer — the 10th leading cause of cancer deaths in the US.

A new analysis from the Progressive Policy Institute (PPI) warns that an accelerating wave of hospital and corporate acquisitions of physician practices is reshaping where and how patients receive care — and how much they pay for it.

In 2002, at age 55, I underwent my first digital rectal exam.

Circulating tumor DNA (ctDNA) is a blood test that looks for tiny pieces of cancer DNA released by dying cells, allowing doctors to detect cancer using a simple blood sample, Dr. Nicholas Hornstein explained in a live interview with CURE at the 2026 Gastrointestinal Cancers Symposium.

Recently, I walked into my doctor’s office and receive my first dose of the HPV vaccine at 24.

“When you hear the words breast cancer patient or survivor, you might picture a woman. But men can and do get breast cancer too,” said Carrie Madrid, founder and president of The CARE Project, Inc.